Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study. (HiGUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04061395
Recruitment Status : Not yet recruiting
First Posted : August 19, 2019
Last Update Posted : August 21, 2019
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
Barbara Horváth, Principal Investigator, University Medical Center Groningen

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 2020
Estimated Study Completion Date : December 2020